27Sep/13

Healthy Eating Benefits Heart Failure Patients, Study Says – Health.com


The Guardian

Healthy Eating Benefits Heart Failure Patients, Study Says
Health.com
FRIDAY, Sept. 27 (HealthDay News) — Healthy eating habits can significantly reduce high blood pressure and improve heart function in heart failure patients, a new study says. The study included patients, most in their 60s and 70s, who ate only meals
September 29 Is World Heart DaySunrise Senior Living Blog (blog)
New fitness app challenges users to walk five million milesThe Guardian

all 17 news articles »

27Sep/13

Halozyme Therapeutics, Inc. (HALO): Halozyme's CEO Presents at BioCentury … – Seeking Alpha

Halozyme Therapeutics, Inc. (HALO): Halozyme’s CEO Presents at BioCentury
Seeking Alpha
If we look across the board whether or not it’d be Roche, product like Herceptin or rituximab, taking these from IV to subcutaneous administration. This is something that we have two products now which have seen European launches in the last quarter

and more »

27Sep/13

Shark blood antibodies may hold potential treatment for breast cancer – CBS News


BBC News

Shark blood antibodies may hold potential treatment for breast cancer
CBS News
The University of Aberdeen received more than $320,000 from the U.K. nonprofit Association for International Cancer Research (AICR) to study “shark IgNAR antibodies.” The three-year study will focus on whether the compounds found in sharks’ blood can 
Breast Cancer: Sharks’ Antibodies Could Hold KeySky News
Shark antibodies ‘may target breast cancer’BBC News
Shark antibodies may aid breast cancer fightTelegraph.co.uk
Examiner.com
all 35 news articles »
27Sep/13

Newly Identified Antibodies Effectively Treat Alzheimer's-Like Disease in Mice – Science Daily (press release)

Newly Identified Antibodies Effectively Treat Alzheimer’s-Like Disease in Mice
Science Daily (press release)
Sep. 26, 2013 — Alzheimer’s disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody